Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar ...

Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system, causing demyelination and degeneration. Although there are disease-modifying treatments that can reduce the ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune system. B ...

Immediately after occupational therapy (OT), people with multiple sclerosis may show small improvements in daily functioning and mental health-related quality of life (HR-QoL), but OT may have little ...

Injectable medications for multiple sclerosis (MS) are known as disease-modifying therapies (DMTs). This means they work by slowing or changing the progression of the condition. These are ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous system and scrambles communication between the brain and body. MS, for which ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory small molecule therapy that can cross the blood-brain barrier may be attractive ...

The myelin sheaths insulating neurons are damaged in multiple sclerosis. Steve Gschmeissner/Science Photo Library/Brand X Pictures via Getty Images The environment plays a key role in determining who ...

Multiple sclerosis (MS) is a chronic, often disabling condition that affects the central nervous system, disrupting communication between the brain and body. It’s largely thought to occur when the ...